BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27266081)

  • 1. [Relationship between the Classification of Diabetic Nephropathy 2014 and the classification of CKD stages].
    Shimizu M; Wada T
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():164-9. PubMed ID: 27266081
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic Nephropathy: A Comparison of the Clinical and Pathological Features between the CKD Risk Classification and the Classification of Diabetic Nephropathy 2014 in Japan.
    Furuichi K; Shimizu M; Hara A; Toyama T; Wada T
    Intern Med; 2018 Dec; 57(23):3345-3350. PubMed ID: 30101924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
    Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
    Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy.
    Haneda M; Utsunomiya K; Koya D; Babazono T; Moriya T; Makino H; Kimura K; Suzuki Y; Wada T; Ogawa S; Inaba M; Kanno Y; Shigematsu T; Masakane I; Tsuchiya K; Honda K; Ichikawa K; Shide K
    Clin Exp Nephrol; 2015 Feb; 19(1):1-5. PubMed ID: 25527479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification of Diabetic Nephropathy 2014].
    Haneda M; Utsunomiya K; Koya D; Babazono T; Moriya T; Makino H; Kimura K; Suzuki Y; Wada T; Ogawa S; Inaba M; Kanno Y; Shigematsu T; Masakane I; Tsuchiya K; Honda K; Ichikawa K; Shide K; ; ; ; ;
    Nihon Jinzo Gakkai Shi; 2014; 56(5):547-52. PubMed ID: 25130030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of seven estimated glomerular filtration rate equations in kidney patients].
    Kovács F; Sárváry E; Remport A
    Orv Hetil; 2013 Mar; 154(11):415-25. PubMed ID: 23477896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKD and Diabetes: What Can We Learn From Their Similarities and Differences?
    Levey AS; Bilous R; Shlipak MG
    Am J Kidney Dis; 2016 Mar; 67(3):360-3. PubMed ID: 26916373
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and management of diabetic nephropathy].
    Kitada M; Koya D
    Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of diabetic nephropathy: a literature review].
    Meza Letelier CE; San Martín Ojeda CA; Ruiz Provoste JJ; Frugone Zaror CJ
    Medwave; 2017 Jan; 17(1):e6839. PubMed ID: 28112712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific elements of diagnosis in diabetic nephropathy].
    Mihai B; Lăcătuşu C; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):329-37. PubMed ID: 17983164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of unlabeled chronic kidney disease among inpatients at a tertiary-care hospital.
    Ferris M; Shoham DA; Pierre-Louis M; Mandhelker L; Detwiler RK; Kshirsagar AV
    Am J Med Sci; 2009 Feb; 337(2):93-7. PubMed ID: 19214023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.
    Li Vecchi M; Fuiano G; Francesco M; Mancuso D; Faga T; Sponton A; Provenzano R; Andreucci M; Tozzo C
    Nephron Clin Pract; 2007; 105(2):c62-7. PubMed ID: 17135770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
    Kacso IM; Kacso G
    Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies.
    Schroeder EB; Goodrich GK; Newton KM; Schmittdiel JA; Raebel MA
    J Comp Eff Res; 2014 Jul; 3(4):359-69. PubMed ID: 25275233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and renal disease risk. Eyes on the end result.
    Long JB
    Adv Nurse Pract; 2007 Aug; 15(8):30-5; quiz 36. PubMed ID: 19998973
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke.
    Bao YS; Song LT; Zhong D; Song AX; Jia XB; Liu RC; Xie RJ; Na SP
    Eur J Clin Invest; 2013 Aug; 43(8):829-35. PubMed ID: 23869408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and old markers of progression of diabetic nephropathy.
    Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.